A Phase I/IIa Study of the Efficacy and Safety of ASN-002 in Adult Patients with Low-Risk Nodular Basal Cell Carcinoma

A Phase I/IIa Study of the Efficacy and Safety of ASN-002 in Adult Patients with Low-Risk Nodular Basal Cell Carcinoma

CONDITION

Cancer

GENDER

Both males and females

AGE GROUP

18 years and above

TRIAL STATUS

Recruiting

Have you been diagnosed with or suspected to have a nodular Basal Cell Carcinoma (BCC)?  

CLINICAL RESEARCH STUDY

We are seeking volunteers with nodular BCC to participate in a research study.

Study medication and surgery are provided free of charge to participants.

To be eligible to participate in the study you must be have been diagnosed with or suspected to have a nodular BCC and have not yet received treatment for your skin cancer.

If you would like to participate or find out more about the trial, please call Dr. Carol Robinson on 0488 965 426 or email at carol.robinson@sinclairdermatology.com.au.

Details of trials can also be found on the below link https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=369151

 

CONTACT DETAILS

Phone Number: 0488965426
Email: carol.robinson@sinclairdermatology.com.au.
Location: East Melbourne, Victoria, Australia

CONTACT SITE

Approved By: Belberry              

Clinical Trial Registry Link: